Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 25364 63 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117700340B reveals homogeneous catalytic route for Iguratimod intermediate. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.